Intas Pharmaceuticals Limited — Telmisartan Exporter Profile
Indian Pharmaceutical Exporter · #3 for Telmisartan · $15.5M export value · DGFT Verified
Intas Pharmaceuticals Limited is the #3 Indian exporter of Telmisartan with $15.5M in export value and 461 verified shipments. Intas Pharmaceuticals Limited holds a 0.1% market share in Telmisartan exports across 19 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.
Intas Pharmaceuticals Limited — Telmisartan Export Profile: Buyers & Destinations
Where Does Intas Pharmaceuticals Limited Export Telmisartan?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MEXICO | $5.3M | 286 | 72.2% |
| PHILIPPINES | $663.2K | 33 | 9.0% |
| CHILE | $467.8K | 19 | 6.3% |
| NETHERLANDS | $267.7K | 58 | 3.6% |
| SINGAPORE | $225.3K | 12 | 3.0% |
| CANADA | $184.8K | 12 | 2.5% |
| TANZANIA | $48.6K | 6 | 0.7% |
| SOUTH AFRICA | $39.8K | 4 | 0.5% |
| KENYA | $33.2K | 7 | 0.4% |
| CONGO | $28.3K | 7 | 0.4% |
Intas Pharmaceuticals Limited exports Telmisartan to 19 countries. The largest destination is MEXICO accounting for 72.2% of Intas Pharmaceuticals Limited's Telmisartan shipments, followed by PHILIPPINES (9.0%) and CHILE (6.3%). These destinations reflect Intas Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Telmisartan from Intas Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ACCORD FARMA S.A. DE C.V. | MEXICO | $3.1M | 218 |
| ACCORD FARMA S A DE C V | MEXICO | $2.0M | 61 |
| TO THE ORDER | TANZANIA | $541.8K | 35 |
| RITEMED PHILS., INC. | PHILIPPINES | $286.5K | 18 |
| LABORATORIOS SAVAL S.A. | CHILE | $238.4K | 8 |
| RITEMED PHILS INC | PHILIPPINES | $148.5K | 6 |
| BROCACEF NL : HUB | NETHERLANDS | $129.6K | 38 |
| APOTHECA MARKETING PTE. LIMITED | SINGAPORE | $119.8K | 3 |
| LABORATORIOS SAVAL S A | CHILE | $111.1K | 5 |
| APOTHECA MARKETING PTE. LTD. | SINGAPORE | $105.5K | 9 |
Intas Pharmaceuticals Limited supplies Telmisartan to 34 buyers globally. The largest buyer is ACCORD FARMA S.A. DE C.V. (MEXICO), followed by ACCORD FARMA S A DE C V (MEXICO) and TO THE ORDER (TANZANIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Telmisartan Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?
India exported $172.2M worth of Telmisartan through 11,086 shipments from 413 suppliers to 132 countries, serving 1,116 buyers globally. Intas Pharmaceuticals Limited contributes $15.5M to this total, accounting for 0.1% of India's Telmisartan exports. Intas Pharmaceuticals Limited ships Telmisartan to 19 countries through 34 buyers.
What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Telmisartan Exports?
Intas Pharmaceuticals Limited's average Telmisartan shipment value is $33.7K per consignment, based on 461 shipments totaling $15.5M. The largest destination is MEXICO (72.2% of Intas Pharmaceuticals Limited's Telmisartan exports).
How Does Intas Pharmaceuticals Limited Compare to Other Indian Telmisartan Exporters?
Intas Pharmaceuticals Limited ranks #3 among 413 Indian Telmisartan exporters with a 0.1% market share. The top 3 exporters are CIPLA LIMITED ($81.0M), INTAS PHARMACEUTICALS LIMITED ($15.5M), MYLAN LABORATORIES LIMITED ($12.0M). Intas Pharmaceuticals Limited processed 461 shipments to 19 destination countries.
What Telmisartan Formulations Does Intas Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMA DRUGS AND MEDI LESPREK 40MG TELMISARTAN 3X10T AS PER INV | $1.5M | 86 |
| PHARMA DRUGS AND MEDI LESPREK 40MG TELMISARTAN 3X10TACC-MXE2 AS PER INV | $1.2M | 37 |
| PHARMA DRUGS AND MEDI LESPREK 40MG TELMISARTAN 3X10T(ACC-MX)E2 AS PER INVTBS | $871.2K | 78 |
| PHARMA DRUGS AND MEDI LESPREK 40MG TELMISARTAN 3X10T ACC MX E2 AS PER INV | $602.5K | 17 |
| PHARMA DRUGS AND MEDI LESPREK 40MG TELMISARTAN 3X10T AS PER INVTBS | $377.2K | 33 |
| PHARMACEUTICAL DRUGS AND MEDICINE - LESPREK 40MG TELMISARTAN 3X10T(ACC-MX)E2 ASPER INVOICE | $251.1K | 7 |
| PHARMA DRUG&MED: TELLMI TELMISART.40MG EACH UNCOATED TABLET CONTAINS: TELMISARTAN PH.EUR. 40 MG | $232.3K | 5 |
| PHARMA DRUGS AND MEDI LESPREK 40MG TELMISARTAN 3X10T(ACC-MX) AS PER INVTBS | $133.0K | 9 |
| PHARMA DRUGS AND MEDI TELMISARTAN 80MG 3X10T PP (RITEMED - PH) AS PER INV | $116.5K | 5 |
| PHARM DRUG&MED:TELMISARTAN 40MG 3X10T PP(RITEMED - PH)EACH UNCOATED TABLET CONTAINS: TELMISARTAN PH. EUR. 40 MGTBS | $111.7K | 6 |
Intas Pharmaceuticals Limited exports 105 distinct Telmisartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS AND MEDI LESPREK 40MG TELMISARTAN 3X10T AS PER with 86 shipments worth $1.5M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Telmisartan to Key Markets
What Intas Pharmaceuticals Limited must comply with to export Telmisartan to its top destination countries
Mexico — COFEPRIS
Approval Process
Generic registration under Mexican health law. NOM standards apply.
Timeline: 12–18 months
GMP & Export Requirements
Mexican GMP (NOM-059-SSA1); COFEPRIS overseas inspection or PIC/S certificate
Sanitary Import Permit from COFEPRIS; import licence via SAT
Note: COFEPRIS participates in PIC/S, easing recognition of PIC/S certificates from Indian authorities.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Intas Pharmaceuticals Limited Compare to Nearest Telmisartan Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | CIPLA LIMITED | $81.0M | 1,619 | 5 | $50.0K |
| 3 | INTAS PHARMACEUTICALS LIMITED ★ | $15.5M | 461 | 19 | $33.7K |
| 2 | MYLAN LABORATORIES LIMITED | $12.0M | 240 | 4 | $50.0K |
| 4 | ARISTO PHARMACEUTICALS PRIVATE LIMITED | $11.6M | 334 | 10 | $34.8K |
Intas Pharmaceuticals Limited ranks #3 among 413 Indian Telmisartan exporters. Average shipment value of $33.7K compared to the market average of $416.8K. The closest competitors by value are CIPLA LIMITED and MYLAN LABORATORIES LIMITED.
Which Indian Ports Ship Telmisartan Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,766 | 15.9% |
| SAHAR AIR | 1,729 | 15.6% |
| DELHI AIR CARGO ACC (INDEL4) | 1,003 | 9.0% |
| NHAVA SHEVA SEA (INNSA1) | 755 | 6.8% |
| DELHI AIR | 623 | 5.6% |
| AHEMDABAD AIR | 402 | 3.6% |
| Bombay Air | 396 | 3.6% |
| JNPT | 377 | 3.4% |
What Other Cardiovascular Products Does Intas Pharmaceuticals Limited Export?
Intas Pharmaceuticals Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Telmisartan Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)
Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.
Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.
About Intas Pharmaceuticals Limited
Intas Pharmaceuticals Limited exports 75 products worth $372.3M. Beyond Telmisartan, top products include Ras, Mycophenolate, Tacrolimus, Apixaban, Ezetimibe. View the complete Intas Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Telmisartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Telmisartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 479 individual customs records matching Intas Pharmaceuticals Limited exporting Telmisartan, covering 105 formulations to 19 countries via 34 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 132+ countries, 1,116+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Telmisartan Export Data from Intas Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Intas Pharmaceuticals Limited's Telmisartan exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Intas Pharmaceuticals Limited
Full Company Profile →
75 products · $372.3M total trade · 19 categories
Telmisartan Stats
Company Overview
Top Products by Intas Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Intas Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Telmisartan. For current shipment-level data, contact TransData Nexus.